HomeInsightsStock Comparison

Thyrocare Technologies Ltd vs Vimta Labs Ltd Stock Comparison

Thyrocare Technologies Ltd vs Vimta Labs Ltd Stock Comparison

Last Updated on: Jul 02, 2025

Key Highlights

  • The Latest Trading Price of Thyrocare Technologies Ltd is ₹ 985 as of 02 Jul 16:01.
  • The P/E Ratio of Thyrocare Technologies Ltd changed from 29.6 on March 2020 to 44.3 on March 2024 . This represents a CAGR of 8.40% over 5 yearsThe P/E Ratio of Vimta Labs Ltd changed from 19.1 on March 2020 to 24 on March 2024 . This represents a CAGR of 4.67% over 5 years.
  • The Market Cap of Thyrocare Technologies Ltd changed from ₹ 2618 crore on March 2020 to ₹ 3135 crore on March 2024 . This represents a CAGR of 3.67% over 5 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 130.94 crore on March 2020 to ₹ 985.7 crore on March 2024 . This represents a CAGR of 49.74% over 5 years.
  • The revenue of Thyrocare Technologies Ltd for the Mar '25 is ₹ 191.75 crore as compare to the Dec '24 revenue of ₹ 169.93 crore. This represent the growth of 12.84% The revenue of Vimta Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 95.13 crore. This represent the decline of -100%.
  • The ebitda of Thyrocare Technologies Ltd for the Mar '25 is ₹ 61.66 crore as compare to the Dec '24 ebitda of ₹ 45.58 crore. This represent the growth of 35.28% The ebitda of Vimta Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 38.29 crore. This represent the decline of -100%.
  • The net profit of Thyrocare Technologies Ltd changed from ₹ 17.25 crore to ₹ 21.57 crore over 8 quarters. This represents a CAGR of 11.82% The net profit of Vimta Labs Ltd changed from ₹ 12.2 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Thyrocare Technologies Ltd changed from 33.31 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 6.61 % on March 2025 . This represents a CAGR of -20.48% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Thyrocare Technologies Ltd

  • Thyrocare Technologies Limited was incorporated in January, 2000.
  • The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
  • Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
  • The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).

About Vimta Labs Ltd

  • Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
  • Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

Thyrocare Technologies Ltd News Hub

News

Thyrocare Technologies allots 996 equity shares under ESOS

Thyrocare Technologies has allotted 996 equity shares under ESOS. With this allotment, the...

Read more

21 May 2025 13:19

News

Thyrocare Tech spurts as Q4 PAT jumps 22% YoY to Rs 22 cr; declares dividend of Rs 21/sh

Profit before tax (PBT) for the March quarter stood at Rs 47.19 crore, marking a robust 10...

Read more

24 Apr 2025 10:07

News

Board of Thyrocare Technologies recommends Final Dividend

Thyrocare Technologies announced that the Board of Directors of the Company at its meeting...

Read more

23 Apr 2025 16:32

News

Thyrocare Technologies to discuss results

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

16 Apr 2025 13:59

News

Thyrocare Tech rises as Q3 PAT jumps 29% YoY to Rs 19 cr

Profit before tax in Q3 FY25 stood at Rs 27.92 crore, up 40.23% from Rs 19.91 crore posted...

Read more

24 Jan 2025 10:03

News

Thyrocare Technologies grants 2,823 stock options under ESOS

Thyrocare Technologies has approved the grant of 2823 stock options to the eligible employ...

Read more

23 Jan 2025 19:33

Vimta Labs Ltd News Hub

News

Vimta Labs allots Equity Shares

Vimta Labs has approved the allotted 2,22,52,784 equity shares of Rs. 2/- each as fully-pa...

Read more

16 Jun 2025 10:39

News

Vimta Labs cancels board meeting

Vimta Labs has cancelled the board meeting which was scheduled to be held on 14 June 2025....

Read more

14 Jun 2025 09:55

News

Vimta Labs to conduct board meeting

Vimta Labs will hold a meeting of the Board of Directors of the Company on 14 June 2025. P...

Read more

07 Jun 2025 10:22

News

Vimta Labs allots 18,272 equity shares under ESOP

Vimta Labs has allotted 18,272 equity shares under ESOP on 23 May 2025. The paid-up share ...

Read more

23 May 2025 16:18

News

Vimta Labs to hold AGM

Vimta Labs announced that the 35th Annual General Meeting(AGM) of the company will be held...

Read more

17 May 2025 12:59

News

Vimta Labs rises after strong Q4 performance; board OKs 1:1 bonus share issue

EBITDA improved by 31.9% to Rs 34.68 crore in Q4 FY25 from Rs 26.30 crore in Q4 FY24. EBIT...

Read more

29 Apr 2025 12:49

SWOT Analysis Of Thyrocare Technologies Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Vimta Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Thyrocare Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vimta Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Thyrocare Technologies Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Thyrocare Technologies Ltd or Vimta Labs Ltd?

Market cap of Thyrocare Technologies Ltd is 5,166 Cr while Market cap of Vimta Labs Ltd is 2,002 Cr

What are the key factors driving the stock performance of Thyrocare Technologies Ltd and Vimta Labs Ltd?

The stock performance of Thyrocare Technologies Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Thyrocare Technologies Ltd and Vimta Labs Ltd?

As of July 2, 2025, the Thyrocare Technologies Ltd stock price is INR ₹974.85. On the other hand, Vimta Labs Ltd stock price is INR ₹450.0.

How do dividend payouts of Thyrocare Technologies Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Thyrocare Technologies Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions